Literature DB >> 2200408

Kidney sialidase and sialyltransferase activities in spontaneously and experimentally diabetic rats. Influence of insulin and sorbinil treatments.

L Cohen-Forterre1, J Andre, G Mozere, J Peyroux, M Sternberg.   

Abstract

Kidney cortex sialic acid level, sialidase and sialyltransferase activities have been measured in spontaneously diabetic BB rats and in streptozotocin-diabetic rats (STZ). In untreated diabetic BB rats, at the onset of the disease, sialidase specific activity was found to be increased by 21% when compared with diabetes-resistant BB controls (P less than 0.05) whereas sialyltransferase activity was not significantly modified and bound sialic acid concentration was diminished (P less than 0.05). In diabetic BB rats submitted to a minimal insulin therapy, during 3 months of disease, sialidase activity and sialic acid concentration were similar to those of Wistar age-matched controls. In STZ-diabetic Wistar rats, sialidase specific activity was increased by 76% after 5 months of disease when compared to age-matched Wistar controls (P less than 0.01); in contrast, specific sialyltransferase activity was decreased by 21% (P less than 0.05); these enzymatic alterations were associated with a decrease in bound sialic acid concentration (P less than 0.01); 1 month's insulin therapy, started 4 months after onset of the disease, normalized sialidase activity but had no effect on sialyltransferase activity and sialic acid concentration; treatment with sorbinil prevented cataract development but had no effect on sialidase activity whereas it emphasized the decrease in sialyltransferase activity and sialic acid concentration. The disturbances in the enzyme activities concerned with sialoglycoconjugate metabolism observed in experimental and spontaneous diabetes may be responsible for the decreased bound sialic acid content observed in the rat kidney cortex.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2200408     DOI: 10.1016/0006-2952(90)90549-z

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  Post-translational modification regulates prostaglandin D2 synthase apoptotic activity: characterization by site-directed mutagenesis.

Authors:  Louis Ragolia; Christopher E Hall; Thomas Palaia
Journal:  Prostaglandins Other Lipid Mediat       Date:  2006-11-07       Impact factor: 3.072

2.  Increases in plasma lysosomal enzymes in type 1 (insulin-dependent) diabetes mellitus: relationship to diabetic complications and glycaemic control.

Authors:  P J Waters; M D Flynn; R J Corrall; C A Pennock
Journal:  Diabetologia       Date:  1992-10       Impact factor: 10.122

3.  Glycosylation failure extends to glycoproteins in gestational diabetes mellitus: evidence from reduced α2-6 sialylation and impaired immunomodulatory activities of pregnancy-related glycodelin-A.

Authors:  Cheuk-Lun Lee; Philip C N Chiu; Poh-Choo Pang; Ivan K Chu; Kai-Fai Lee; Riitta Koistinen; Hannu Koistinen; Markku Seppälä; Howard R Morris; Bérangère Tissot; Maria Panico; Anne Dell; William S B Yeung
Journal:  Diabetes       Date:  2011-02-07       Impact factor: 9.461

4.  Beneficial effects of tyrosol on altered glycoprotein components in streptozotocin-induced diabetic rats.

Authors:  Ramasamy Chandramohan; Settu Saravanan; Leelavinothan Pari
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 5.  Immunobiology of Gestational Diabetes Mellitus in Post-Medawar Era.

Authors:  Surendra Sharma; Sayani Banerjee; Paula M Krueger; Sandra M Blois
Journal:  Front Immunol       Date:  2022-01-03       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.